Compare FTRE & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTRE | MMI |
|---|---|---|
| Founded | 1996 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2023 | 2013 |
| Metric | FTRE | MMI |
|---|---|---|
| Price | $19.79 | $30.71 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | $14.06 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 970.2K | 90.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | N/A | ★ 84.38 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $2,723,400,000.00 | $719,700,000.00 |
| Revenue This Year | N/A | $14.04 |
| Revenue Next Year | $3.09 | $11.35 |
| P/E Ratio | ★ N/A | $1,563.50 |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $8.31 | $24.43 |
| 52 Week High | $21.39 | $33.55 |
| Indicator | FTRE | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 45.16 | 44.77 |
| Support Level | $17.37 | $29.69 |
| Resistance Level | $18.13 | $32.34 |
| Average True Range (ATR) | 0.77 | 0.61 |
| MACD | -0.13 | -0.14 |
| Stochastic Oscillator | 40.95 | 21.96 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans. The Company has one reportable segment: commercial real estate services. The commercial real estate services segment is the aggregation of our two operating segments: investment sales and financing services.